Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128977) titled 'Efficacy and Safety of Daridorexant in Treating Sleep Disorders in Patients with Hepatocellular Carcinoma' on July 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Sleep Disorder
Intervention:
Trial group:Dalirese treatment for 4 weeks
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Trial group:95;Control group:95;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334836
Published by HT Digital Content Services with permi...